no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
|
Bowman, Louise |
|
2018 |
198 |
C |
p. 135-144 |
article |
2 |
A “shocking” new code status
|
Mandawat, Anant |
|
2018 |
198 |
C |
p. 1-3 |
article |
3 |
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial
|
van der Heijden, Liefke C. |
|
2018 |
198 |
C |
p. 25-32 |
article |
4 |
Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation
|
Fauchier, Laurent |
|
2018 |
198 |
C |
p. 39-45 |
article |
5 |
Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non–vitamin K antagonist oral anticoagulants
|
Miyazawa, Kazuo |
|
2018 |
198 |
C |
p. 166-168 |
article |
6 |
Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data
|
Galper, Benjamin Z. |
|
2018 |
198 |
C |
p. 64-74 |
article |
7 |
Editorial Board
|
|
|
2018 |
198 |
C |
p. v |
article |
8 |
Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis
|
Hijazi, Ziad |
|
2018 |
198 |
C |
p. 169-177 |
article |
9 |
Factors of health in the protection against death and cardiovascular disease among adults with subclinical atherosclerosis
|
Al Rifai, Mahmoud |
|
2018 |
198 |
C |
p. 180-188 |
article |
10 |
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)
|
Bergmeijer, Thomas O. |
|
2018 |
198 |
C |
p. 152-159 |
article |
11 |
Government continues to have an important role in promoting cardiovascular health
|
Tomaselli, Gordon |
|
2018 |
198 |
C |
p. 160-165 |
article |
12 |
Health promotion: A step beyond prevention in cardiology
|
Bittencourt, Marcio Sommer |
|
2018 |
198 |
C |
p. 178-179 |
article |
13 |
Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction
|
Rymer, Jennifer A. |
|
2018 |
198 |
C |
p. 97-107 |
article |
14 |
Impact of hormone therapy on Medicare spending in the Women’s Health Initiative randomized clinical trials
|
Shreibati, Jacqueline B. |
|
2018 |
198 |
C |
p. 108-114 |
article |
15 |
Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles
|
Navar, Ann Marie |
|
2018 |
198 |
C |
p. 18-24 |
article |
16 |
Information for Readers
|
|
|
2018 |
198 |
C |
p. x |
article |
17 |
Left ventricular ejection fraction reassessment post–myocardial infarction: Current clinical practice and determinants of adverse remodeling
|
Chew, Derek S. |
|
2018 |
198 |
C |
p. 91-96 |
article |
18 |
Outcomes of hospitalization in adults with Fontan palliation: The Mayo Clinic experience
|
Egbe, Alexander |
|
2018 |
198 |
C |
p. 115-122 |
article |
19 |
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry
|
Khazanie, Prateeti |
|
2018 |
198 |
C |
p. 123-128 |
article |
20 |
Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial
|
Bishawi, Muath |
|
2018 |
198 |
C |
p. 33-38 |
article |
21 |
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
|
Cacoub, Patrice |
|
2018 |
198 |
C |
p. 4-17 |
article |
22 |
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial
|
Velazquez, Eric J. |
|
2018 |
198 |
C |
p. 145-151 |
article |
23 |
Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial
|
Berwanger, Otavio |
|
2018 |
198 |
C |
p. 129-134 |
article |
24 |
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients
|
Gibson, C. Michael |
|
2018 |
198 |
C |
p. 84-90 |
article |
25 |
Table of Contents
|
|
|
2018 |
198 |
C |
p. i-iv |
article |
26 |
Temporal changes in radial access use, associates and outcomes in patients undergoing PCI using rotational atherectomy between 2007 and 2014: results from the British Cardiovascular Intervention Society national database
|
Kinnaird, Tim |
|
2018 |
198 |
C |
p. 46-54 |
article |
27 |
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry
|
Huisman, Menno V. |
|
2018 |
198 |
C |
p. 55-63 |
article |
28 |
Ultrahigh-resolution ultrasound characterization of access site trauma and intimal hyperplasia following use of a 7F sheathless guide versus 6F sheath/guide combination for transradial artery PCI: Results of the PRAGMATIC trial
|
Batchelor, Wayne |
|
2018 |
198 |
C |
p. 75-83 |
article |